EPIGENOMICS-UK 润色咨询

Epigenomics

出版年份:2009 年文章数:1126 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:4.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=988611238, cover=https://img.medsci.cn/20231105/1699202099534_4754896.jpg, fullname=Epigenomics, abbr=EPIGENOMICS-UK, pyear=2009, frequence=Bimonthly, articleNumbers=1126, citedSelf2015=4.3, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均2月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1750-1911, greenSci=https://www.greensci.net/search?kw=1750-1911, scijournal=https://www.scijournal.org/impact-factor-of-EPIGENOMICS-UK.shtml, medsciHotlightString=null, medsciHotlightRealtime=7.593, medsciHotlight=11.361, medsciHotlight5year=8.73131, citescore=5.9, hIndex=60, impactFactor=3.8, orgnization=Future Medicine Ltd., orgnizationUrl=null, country=United Kingdom, countryCn=英国, isOa=1, isOaString=是, sciScie=Science Citation Index Expanded|BIOSIS Previews|BIOSIS Reviews Reports And Meetings, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=https://www.futuremedicine.com/journal/epi, websiteHits=5092, guideForAuthor=https://www.futuremedicine.com/authorguide, guideForAuthorHits=42, submitWebsite=https://mc04.manuscriptcentral.com/fm-epi, submitWebsiteHits=1942, content=<p style="color: #333333;">One of the most exciting developments to come out of the completion of the Human Genome Project in 2003 was the emergence of the new field of epigenomics – the study of epigenetic modification at a level outside the single gene. While epigenetics refers to the study of single genes or groups of genes, epigenomics refers to the wider global analyses of epigenetic changes across the entire genome.</p> <p style="color: #333333;">The blueprint of our genes may have been defined by the Human Genome Project but the rules governing them are prescribed by the science of epigenomics. Therefore, the origins of health and susceptibility to disease are, in part, the result of epigenetic regulation of the genetic blueprint.</p> <p style="color: #333333;"><em>Epigenomics</em> promises to elucidate the inner workings of the genome. The power of this new discipline lies in its promise to provide us with novel insights into the inner workings of our genomes through its potential to detect quantitative changes, multiple modifications and the regulatory sequences outside that of our gene sequences. The advent of numerous epigenomics strategies has emerged to detect large numbers of DNA methylation variations and chromatin modifications – two mechanisms that are at the core of epigenomic research.</p> <p style="color: #333333;">With the creation of the Human Epigenome Project, many research groups have joined forces to further elucidate and exploit new technologies to better understand the basis of normal development and human disease.</p> <p style="color: #333333;"><em>Epigenomics</em> provides the forum to address the rapidly progressing research developments in this ever-expanding field; to report on the major challenges ahead and critical advances that are propelling the science forward. The journal delivers this information in concise, at-a-glance article formats – invaluable to a time constrained community.</p> <p style="color: #333333;">Substantial developments in our current knowledge and understanding of genomics and epigenetics are constantly being made. In recent years, <em>Epigenomics</em> has responded to the shift in research focus from solely DNA methylation and cancer onto non-coding RNAs, bioinformatics, neuroepigenetics, immunoepigenetics, <em>in utero</em> environment/pre- and peri-natal environment, pollutants and other environmental stressors, behavioural epigenetics, and much more.</p> <p style="color: #333333;"><em>Epigenomics</em> provides a critical overview of the latest and most significant advances as they unfold and explores their potential application in the clinical setting.</p> <p style="color: #333333;">Articles published in <em>Epigenomics</em> cover key areas such as:</p> <ul style="color: #333333;" type="disc"> <li>Array technologies in epigenomics</li> <li>Cancer epigenetics</li> <li>Chromatin remodelling</li> <li>Cutting-edge epigenomic techniques & tools</li> <li>Data analysis, algorithms and computational approaches</li> <li>Diagnosis and prognosis in human disease</li> <li>DNA methylation profiling</li> <li>Environmental epigenetics</li> <li>Epigenetic mechanisms and effects</li> <li>Genomic imprinting</li> <li>Population-scale studies</li> <li>Therapeutic implications of the epigenome</li> </ul>, totalCites=4279, brief=EPIGENOMICS-UK杂志生物行业,暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=EPIGENOMICS-UK杂志级别还可以,但是相对来说,比较冷门,关注人数偏少,有些可能是国内不太熟悉,但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿,稿源可能未必丰富,发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=988611238'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=28185, tagName=生物信息学, createdHits=4), ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=3), ImpactFactorTagDto(id=3225, tagName=表观遗传学, createdHits=2), ImpactFactorTagDto(id=41478, tagName=表观基因组学, createdHits=1), ImpactFactorTagDto(id=42352, tagName=转录组学, createdHits=1), ImpactFactorTagDto(id=15372, tagName=表观遗传, createdHits=1), ImpactFactorTagDto(id=57838, tagName=生信, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=3.29), GetImpactFactorCiteScoreListResponse(year=2017, citescore=3.71), GetImpactFactorCiteScoreListResponse(year=2018, citescore=4.0), GetImpactFactorCiteScoreListResponse(year=2019, citescore=6.5), GetImpactFactorCiteScoreListResponse(year=2020, citescore=5.9)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=12.365), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=13.081), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=12.723), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=8.228), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=7.593)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Genetics , rank=61/318), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Cancer Research , rank=59/191)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=GENETICS & HEREDITY, rank=Q1)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1750-1911[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=EPIGENOMICS[ta], article_number=111, article_number_cn=32, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
EPIGENOMICS-UK/Epigenomics
ISSN
1750-1911
影响指数话题
预警等级
MedSci期刊指数
7.593 (MedSci实时期刊指数) | 8.73131 (5年期刊指数)
CiteScore值
5.9
h-index
60
h5-median
暂无数据
出版社/管理机构
杂志由 Future Medicine Ltd. 出版或管理
出版国家/地区
United Kingdom 英国
出版周期
Bimonthly
出版年份
2009
是否OA
被收录情况
Science Citation Index Expanded|BIOSIS Previews|BIOSIS Reviews Reports And Meetings
JCR分区
GENETICS & HEREDITY Q1
中科院分区
大类:医学 2区
小类:医学 2 区